Table 2 Text mining score and overall association score of cancer types associated with CHI3L1, EGFR, and VEGF on the Open Targets Platform.
From: Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
CHI3L1-cancer | EGFR-cancer | VEGF-cancer | ||||||
|---|---|---|---|---|---|---|---|---|
Name | Text Mining | Overall Association Score | Name | Text Mining | Overall Association Score | Name | Text Mining | Overall Association Score |
Hepatocellular carcinoma | 0.780 | 0.095 | Non-small cell lung carcinoma | 0.891 | 0.854 | Non-small cell lung carcinoma | 0.790 | 0.602 |
Melanoma | 0.672 | 0.082 | Lung cancer | 0.813 | 0.755 | Breast cancer | 0.786 | 0.605 |
Non-small cell lung carcinoma | 0.669 | 0.083 | Glioblastoma multiforme | 0.795 | 0.729 | Hepatocellular carcinoma | 0.785 | 0.581 |
Urinary bladder carcinoma | 0.657 | 0.080 | Lung adenocarcinoma | 0.788 | 0.728 | Neoplasm | 0.784 | 0.569 |
Small cell lung carcinoma | 0.653 | 0.079 | Head and neck squamous cell carcinoma | 0.767 | 0.691 | Glioblastoma multiforme | 0.779 | 0.596 |
Colorectal carcinoma | 0.646 | 0.079 | Neoplasm | 0.716 | 0.622 | Renal cell carcinoma | 0.750 | 0.535 |
Breast cancer | 0.639 | 0.078 | Squamous cell carcinoma | 0.701 | 0.607 | Multiple myeloma | 0.653 | 0.135 |
Esophageal squamous cell carcinoma | 0.628 | 0.076 | Breast cancer | 0.699 | 0.612 | Melanoma | 0.641 | 0.330 |
Diffuse large B-cell lymphoma | 0.608 | 0.074 | Squamous cell lung carcinoma | 0.683 | 0.624 | Lung adenocarcinoma | 0.594 | 0.366 |
In situ carcinoma | 0.604 | 0.073 | Breast carcinoma | 0.674 | 0.632 | Cancer | 0.571 | 0.150 |
Skin squamous cell carcinoma | 0.565 | 0.069 | Metastatic colorectal cancer | 0.638 | 0.555 | Esophageal adenocarcinoma | 0.554 | 0.103 |
Glioblastoma multiforme | 0.494 | 0.069 | Pancreatic carcinoma | 0.604 | 0.625 | Osteosarcoma | 0.538 | 0.117 |
Lymph node metastatic carcinoma | 0.490 | 0.060 | Glioma | 0.595 | 0.572 | Esophageal squamous cell carcinoma | 0.532 | 0.115 |
Invasive breast ductal carcinoma | 0.489 | 0.059 | Lung carcinoma | 0.578 | 0.564 | Glioblastoma | 0.526 | 0.114 |
Invasive lobular carcinoma | 0.456 | 0.055 | Colorectal adenocarcinoma | 0.573 | 0.682 | Intrahepatic cholangiocarcinoma | 0.525 | 0.111 |
Esophageal carcinoma | 0.447 | 0.054 | Thyroid carcinoma | 0.572 | 0.455 | Acute myeloid leukemia | 0.521 | 0.113 |
Astrocytoma | 0.439 | 0.055 | Brain cancer | 0.562 | 0.437 | Nonpapillary renal cell carcinoma | 0.520 | 0.113 |
Glioblastoma | 0.435 | 0.053 | Brain neoplasm | 0.556 | 0.428 | Squamous cell carcinoma | 0.517 | 0.131 |
Pancreatic ductal adenocarcinoma | 0.355 | 0.046 | Head and neck malignant neoplasia | 0.517 | 0.646 | Adenomyosis | 0.513 | 0.087 |
Pulmonary fibrosis | 0.331 | 0.040 | Colorectal carcinoma | 0.515 | 0.445 | Triple-negative breast cancer | 0.500 | 0.133 |